Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system

Area of Science:

• Biochemistry
• Pharmacology
• Cardiovascular Science

Background:

• Eicosanoids, derived from arachidonic acid via cyclooxygenase (COX) enzymes, are key lipid mediators in health and disease.
• Prostacyclin, a well-studied prostanoid, plays a critical role in cardiovascular protection.
• COX-2 is a therapeutic target for NSAIDs, commonly used pain medications.

Purpose of the Study:

• To review the history, biology, and cardiovascular functions of eicosanoids, focusing on prostacyclin and other COX products.
• To discuss the application of eicosanoid pathway knowledge in future drug discovery.
• To elucidate the mechanisms behind NSAID-induced cardiovascular side effects.

Main Methods:

• Literature review of eicosanoid and prostacyclin research.
• Analysis of cyclooxygenase (COX) enzyme functions and isoforms.
• Examination of therapeutic applications and side effects of NSAIDs.

Main Results:

• Eicosanoids and prostacyclin have fundamental roles in cardiovascular physiology and disease.
• Knowledge of these pathways has led to therapies for pulmonary arterial hypertension and peripheral vascular disease.
• The precise mechanisms of NSAID cardiovascular side effects remain a significant and controversial question.

Conclusions:

• Understanding eicosanoid pathways is crucial for advancing cardiovascular medicine and drug discovery.
• Further research is needed to fully explain and mitigate NSAID-related cardiovascular risks.
• Prostacyclin's protective role highlights the complexity of lipid mediator signaling in the cardiovascular system.